Shares of microcap biotech firm Neuralstem (CUR +42%) are soaring today, after it says its...

|By:, SA News Editor

Shares of microcap biotech firm Neuralstem (CUR +42%) are soaring today, after it says its neural stem cells were featured as part of a published study in the scientific journal Cell. In the study, paraplegic rats with surgically transected spinal cords recovered significant locomotor function after being transplanted with CUR's spinal cord stem cells. The transplanted cells turned into neurons which grew a "remarkable" number of axons that extended for "very long distances."